Core Viewpoint - 华检医疗 has experienced a significant stock price increase, with a cumulative rise of over 500% since July 14, 2023, and a current trading price of 11.95 HKD [1] Group 1: Strategic Developments - On August 8, 2023, 华检医疗 announced the launch of its "Global Enhanced Ethereum (ETH) Treasury" strategy and established a global strategic partnership with HashKey Group [1] - A signing ceremony for the global strategic cooperation and the upgrade of the Global Enhanced Ethereum (ETH) Treasury strategy was held on August 11, 2023, at HashKey's office in Hong Kong [1] Group 2: Collaborations and Investments - On July 30, 2023, 华检医疗 signed a strategic cooperation framework agreement with 华大共赢 to jointly establish the "华检华大共赢 Innovative Drug Intellectual Property Tokenization Fund" [1] - The fund aims to invest in 华检医疗's "NewCo+RWA" Web3 trading ecosystem projects in Hong Kong, the United States, and other locations [1] - 华大共赢, initiated by the biotechnology leader 华大基因, has extensive experience and resources in the fields of innovative medicine and drug investment [1]

Core Viewpoint - Huajian Medical Holdings Limited (01931) has officially launched the "Global Enhanced Ethereum (ETH) Treasury" strategy in collaboration with HashKey Group, marking a significant step into the Web3 financial sector for the healthcare industry [1][5]. Group 1: Strategic Collaboration - The partnership will involve signing a global strategic cooperation framework agreement, leveraging HashKey Group's comprehensive compliance ecosystem to provide Huajian Medical with one-stop digital asset management services [2]. - The collaboration will focus on large-scale Ethereum (ETH) trading execution, cost optimization, and exploring the tokenization of real-world assets (RWA) related to innovative medical drug intellectual property [2][5]. Group 2: Enhanced Ethereum Treasury Strategy - The upgrade of the "Global Enhanced Ethereum (ETH) Treasury" will be announced, aiming to create a safer, more efficient, and compliant digital asset service system [3]. - This strategy will provide innovative asset allocation paths for global investors and facilitate the global circulation of medical innovation drug intellectual property [3][5]. Group 3: Industry Impact - The collaboration is expected to reshape the financial infrastructure of the healthcare industry by injecting real economic value into the digital asset sector [6]. - By utilizing blockchain technology's traceability and transparency, the partnership aims to establish a trust bridge between medical intellectual property and digital assets, offering new pathways for global investors to engage in medical innovation [6].

Core Viewpoint - The company has signed a global strategic cooperation framework agreement with HashKey Group to enhance its digital asset services and implement its "Global Enhanced Ethereum (ETH) Treasury" strategy [1] Group 1 - The agreement aims to accelerate the implementation of the company's strategic initiatives in the digital asset space [1] - The collaboration is expected to provide more efficient, secure, and compliant digital asset services to global clients [1]

Core Viewpoint - The company has signed a global strategic cooperation framework agreement with HashKey Group to accelerate the implementation of its "Global Enhanced Ethereum (ETH) Vault" strategy and provide efficient, secure, and compliant digital asset services to global clients [1][2]. Group 1: Strategic Cooperation - The cooperation aims to leverage HashKey Group's fully licensed compliance ecosystem to provide one-stop digital asset management services, including bulk trading execution and cost optimization for Ethereum (ETH) [2][3]. - The partnership will enhance the company's ability to manage Ethereum (ETH) reserves, optimize trading costs, and access broader market resources and technical support globally [2][3]. Group 2: Ethereum (ETH) Trading Execution and Cost Optimization - HashKey Group will provide professional bulk trading execution services for Ethereum (ETH) through its compliant trading platform, ensuring transactions are executed at optimal prices and costs are further optimized through OTC services [3]. Group 3: Global Market Liquidity Support - HashKey Group's global trading platform will support the company's Ethereum (ETH) vault strategy by providing sufficient liquidity and real-time market insights to optimize investment decisions [4]. Group 4: Integration of Crypto Assets and Real Economy Assets - The collaboration will explore the integration of crypto asset reserves with real economy assets, particularly in the field of medical innovation and intellectual property tokenization, enhancing the efficiency of drug development and funding [5]. Group 5: Future Outlook - The company plans to deepen its collaboration with HashKey Group and explore innovative cooperation models to enhance its competitiveness and influence in the global Web3 space [6]. Group 6: Upcoming Event - A signing ceremony and strategic upgrade announcement event will be held on August 11, 2025, in Hong Kong, showcasing the cooperation's value and strategic blueprint [7][8].